Type 1 diabetes is caused by the immune system mistakenly attacking and destroying the insulin-producing cells in the pancreas. Unlike type 2 diabetes, which is driven by lifestyle and metabolic factors, type 1 is an autoimmune disease with roots in genetics and environmental triggers. Around 9 million people worldwide live with it, and the process that leads to diagnosis often begins months or years before any symptoms appear.
The Autoimmune Attack on the Pancreas
Your pancreas contains clusters of cells called islets, and within those islets are beta cells, the only cells in your body that produce insulin. In type 1 diabetes, the immune system identifies these beta cells as foreign threats and launches a sustained attack against them. Two types of immune cells drive the destruction: one type orchestrates the overall assault, while another directly kills the beta cells. As more beta cells are destroyed, insulin production drops until the body can no longer regulate blood sugar on its own.
This destruction doesn’t happen overnight. The immune system can be quietly attacking beta cells for months or even years before blood sugar levels become noticeably abnormal. By the time someone is diagnosed with symptoms like extreme thirst, frequent urination, and unexplained weight loss, a significant portion of their beta cells has already been lost.
Genetics: The Strongest Known Risk Factor
Certain inherited gene variants dramatically increase the likelihood of developing type 1 diabetes. The most important genes sit in a region of DNA that controls how the immune system distinguishes the body’s own cells from invaders. Specific combinations of these genes can raise risk substantially, while other combinations are protective.
The highest-risk genetic profile is a particular combination called DR3/4-DQ8. Research published in PNAS showed just how powerful this genetic signal is within families: siblings who carried this high-risk combination and shared both copies of the relevant gene region with a sibling who already had type 1 diabetes had an 85% chance of developing immune markers of the disease by age 15. Among those siblings, 55% developed diabetes by age 12. By contrast, siblings who didn’t share those same gene copies had roughly a 5% chance.
Even among people with the high-risk gene combination, though, sharing the exact same inherited copies from both parents mattered enormously. Siblings who carried the high-risk combination but didn’t share both copies with their affected sibling had only a 25% risk by age 12. This tells us that the specific version of these genes you inherit, not just the general type, shapes your risk in a meaningful way.
That said, most people who carry high-risk genes never develop type 1 diabetes. Genetics loads the gun, but something else pulls the trigger.
Viral Infections as a Trigger
Enteroviruses, a large family of common viruses that includes the Coxsackie B group, are the most studied environmental trigger for type 1 diabetes. These viruses can directly infect the insulin-producing beta cells in the pancreas through a receptor found on the surface of those cells. Once inside, the virus can kill beta cells, reduce insulin production, and damage the internal machinery the cell needs to function.
A meta-analysis of 38 case-control studies found a consistent association between enterovirus infection and type 1 diabetes risk. Importantly, researchers have detected enterovirus RNA in the blood of children who later went on to develop immune markers of the disease, often several months before autoimmunity appeared. Both acute infections and low-grade persistent infections seem capable of affecting beta cell function, suggesting the virus doesn’t need to cause a dramatic illness to do damage.
The working theory is that a viral infection in someone with genetic susceptibility can break the immune system’s tolerance of beta cells. The virus may damage beta cells enough to expose proteins the immune system hasn’t seen before, or the virus itself may share structural similarities with beta cell proteins, confusing the immune system into attacking both.
The Hygiene Hypothesis
A counterintuitive pattern has emerged over decades of research: type 1 diabetes rates are highest in wealthy, developed countries with high standards of sanitation. The hygiene hypothesis proposes that children in cleaner environments encounter fewer infections during the critical window when their immune systems are learning what to attack and what to leave alone. Without enough early microbial exposure, the immune system may be more prone to turning on the body’s own tissues.
A study published in JAMA Pediatrics found supporting evidence. Children with three or more older siblings had a 44% lower risk of developing type 1 diabetes compared to children with fewer siblings. Sharing a bedroom, living in more crowded conditions, and attending daycare, all situations that increase exposure to germs early in life, were also associated with lower risk. The logic is straightforward: more siblings and more social contact in early childhood mean more infections, which may help calibrate the immune system properly.
How the Disease Develops in Stages
Type 1 diabetes doesn’t begin with symptoms. Researchers now recognize three distinct stages, and this framework is changing how the disease is detected and understood.
- Stage 1: The immune system has begun producing autoantibodies, proteins that target beta cells. At least two types of autoantibodies are detectable in blood tests, but blood sugar levels are still completely normal and there are no symptoms. A person can remain in this stage for years.
- Stage 2: Beta cell destruction has progressed far enough that blood sugar regulation starts to slip. Autoantibodies are still present and blood sugar levels are now abnormal, but there are still no obvious symptoms. This stage represents a narrowing window before clinical diabetes.
- Stage 3: Enough beta cells have been destroyed that the body can no longer maintain blood sugar on its own. This is the point of clinical diagnosis, when symptoms like excessive thirst, frequent urination, fatigue, and weight loss typically appear.
This staging matters because screening programs can now identify people in Stage 1 or 2, sometimes years before they would have been diagnosed. The four autoantibodies that doctors test for target insulin, an enzyme called GAD, a protein called IA-2, and a zinc transporter found on beta cells. Testing positive for two or more of these autoantibodies on separate occasions is the current standard for identifying presymptomatic type 1 diabetes.
Why Some People Get It and Others Don’t
The honest answer is that no single factor causes type 1 diabetes. It requires a collision of genetic vulnerability and environmental exposure, and likely some element of timing or bad luck. Identical twins, who share all their DNA, have roughly a 50% concordance rate, meaning half the time only one twin develops the disease. That gap points to the role of non-genetic factors.
Other environmental suspects beyond viruses include early diet (particularly early exposure to cow’s milk protein or gluten), vitamin D deficiency, and changes in gut bacteria composition, though none of these have evidence as strong as the enterovirus connection. The rising incidence of type 1 diabetes in developed countries over the past several decades, a timeline too fast to be explained by genetics alone, strongly suggests that something about modern environments is contributing.
What is clear is that type 1 diabetes is not caused by eating too much sugar, being overweight, or any lifestyle choice. It is an autoimmune disease with biological causes that begin long before symptoms appear.